Fact-finding survey of diabetic macular edema using big data and in clinical practice and examination of the usefulness of SGLT2 inhibitors

Fact-finding survey of diabetic macular edema using big data and in clinical practice and examination of the usefulness of SGLT2 inhibitors - Fact-finding survey of diabetic macular edema using big data and in clinical practice and examination of the usefulness of SGLT2 inhibitors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042242

Enrollment

1000

Registered

2020-10-27

Start date

2021-04-15

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic macular edema

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients being treated for diabetic macular edema

Exclusion criteria

Exclusion criteria: Patients with less than 6 months of hospital visits

Design outcomes

Primary

Measure	Time frame
The number of anti-VEGF injections per year in patients with diabetic macular edema with and without SGLT2 inhibitors.	—

Countries

Japan

Contacts

Public ContactRyoichi Ishibashi

Kimitsu Chuo Hospital Department of Medicine, Division of Diabetes, Endocrinology and Metabolism

ishibashi-cib@umin.net+81-438-36-1071

Outcome results